Evidence map›Paper›PMID 30400258›Full record

ArticleCells2018

Dysregulation of the Immune System in HIV/HCV-Coinfected Patients According to Liver Stiffness Status.

Pilar Garcia-Broncano, Luz Maria Medrano, Juan Berenguer, Juan González-García, Mª Ángeles Jiménez-Sousa, Ana Carrero, Victor Hontañón, Josep M Guardiola, Manuel Crespo, Carmen Quereda and 5 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Plasma Inflammatory Biomarkers Associated with Advanced Liver Fibrosis in HIV-HCV-Coinfected Individuals.International journal of environmental research and public health · 2020
    Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 2 countries.

Pilar Garcia-BroncanoRagon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA. pgarciabroncano@gmail.com.ORCID 0000-0002-3413-2189
Luz Maria MedranoViral Infection and Immunity Unit, National Center of Microbiology, Health Institute Carlos III, 28220 Madrid, Spain. luzmedranodios@gmail.com.
Juan BerenguerInfectious Disease/HIV Unit, Gregorio Marañón G. University Hospital, 28007 Madrid, Spain. jbb4@me.com.ORCID 0000-0001-8541-8200
Juan González-GarcíaHIV Unit, Internal Medicine Service, La Paz University Hospital, 28046 Madrid, Spain. juangonzalezgar@gmail.com.
Mª Ángeles Jiménez-SousaViral Infection and Immunity Unit, National Center of Microbiology, Health Institute Carlos III, 28220 Madrid, Spain. jimenezsousa@isciii.es.
Ana CarreroInfectious Disease/HIV Unit, Gregorio Marañón G. University Hospital, 28007 Madrid, Spain. ana_carrero@yahoo.es.
Victor HontañónHIV Unit, Internal Medicine Service, La Paz University Hospital, 28046 Madrid, Spain. victor.hontanon@gmail.com.
Josep M GuardiolaSanta Creu i Sant Pau Hospital, 08041 Barcelona, Spain. jguardiola@santpau.es.
Manuel CrespoInfectious Disease Unit, Internal Medicine Department, Vigo University Hospital Complex, Galicia Sur Health Research Institute, 36312 Vigo, Pontevedra, Spain. manuelcrespocasal@gmail.com.
Carmen QueredaRamón y Cajal University Hospital, 28034 Madrid, Spain. cqueredar.hrc@salud.madrid.org.
José SanzPríncipe de Asturias University Hospital, 28805 Madrid, Spain. jsanz.hupa@salud.madrid.org.
Ana Belen García-GómezViral Infection and Immunity Unit, National Center of Microbiology, Health Institute Carlos III, 28220 Madrid, Spain. piperangarcia@yahoo.es.
Jose Luis JimenezGregorio Marañón Health Research Institute, 28007 Madrid, Spain. joseluis.jimenez@salud.madrid.org.
Salvador ResinoViral Infection and Immunity Unit, National Center of Microbiology, Health Institute Carlos III, 28220 Madrid, Spain. sresino@isciii.es.ORCID 0000-0001-8783-0450
GESIDA 3603b Study Group
Instituto de Salud Carlos III · ESHospital General Universitario Gregorio Marañón · ESHospital Universitario La Paz · ESHospital de Sant Pau · ESHospital Universitario Príncipe de Asturias · ESInstituto Cajal · ESRagon Institute of MGH, MIT and Harvard · USUniversity Hospital Complex Of Vigo · ES

Funding

Instituto de Salud Carlos III PI14/01094 and PI17/00657 to JB, PI14/01581 and PI17/00903 to JGG, PI14CIII/00011 and PI17CIII/00003 to SR, and PI17/01115 to JLJ
6 · The paper itself

Abstract

backgroundAdvanced cirrhosis is related to alterations in immunity. We aimed to evaluate the levels of peripheral CD4⁺ T cells (Tregs) and plasma cytokine in patients coinfected with human immunodeficiency virus and hepatitis C virus (HIV/HCV) according to liver fibrosis stages [evaluated as liver stiffness measure (LSM)] and their linear relationship.

methodsWe performed a cross-sectional study on 238 HIV/HCV-coinfected patients (119 had <12.5 kPa, 73 had 12.5⁻25 kPa, and 46 had >25 kPa). Peripheral T-cell subsets were phenotyped by flow cytometry, plasma biomarkers were assessed by multiplex immunoassays, and LSM was assessed by transient elastography. Results

conclusionHIV/HCV-coinfected patients showed an immunosuppressive profile compared to healthy controls and HIV-monoinfected patients. Additionally, HIV/HCV-coinfected patients with advanced cirrhosis (LSM ≥ 25 kPa) had the lowest plasma values of cytokines related to Th1 (IL-2 and TNF-α) and Th17 (IL-17A) response.

Indexed as

chronic hepatitis CcirrhosiscytokinesHIVimmune dysfunctionTreg cells

Identifiers

PMID30400258
PMCPMC6262386
OpenAlexW2899512540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.